The genotoxicity of the anti-cancer drug mitoxantrone in somatic and germ cells of Drosophila melanogaster
- 1 May 1992
- journal article
- Published by Elsevier in Mutation Research/Genetic Toxicology
- Vol. 279 (1) , 21-33
- https://doi.org/10.1016/0165-1218(92)90262-x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Statistical methods to decide whether mutagenicity test data from Drosophila assays indicate a positive, negative, or inconclusive resultPublished by Elsevier ,2003
- The effect of a range of anti-cancer drugs in the white-ivory somatic mutation test in DrosophilaMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1990
- Somatic recombination and mutation assays in Drosophila: A comparison of the response of two different strains to four mutagensMutation Research Letters, 1988
- The Drosophila wing test: A comparison of the sensitivity of different strainsMutation Research/Environmental Mutagenesis and Related Subjects, 1988
- Genotoxicity of the DNA-synthesis inhibitors hydroxyurea and aminopterin in the wing spot test of DrosophilaMutation Research/Environmental Mutagenesis and Related Subjects, 1987
- Aristolochic acid is mutagenic and recombinogenic in Drosophila genotoxicity testsArchives of Toxicology, 1985
- Mutagenicity of adriamycin in Drosophila melanogasterMutation Research/Genetic Toxicology, 1984
- Disposition of mitoxantrone in patientsCancer Treatment Reviews, 1983
- Molecular and biochemical pharmacology of mitoxantroneCancer Treatment Reviews, 1983
- The mutagenic properties of the nucleosides of pyrimidine analogues in Drosophila melanogasterBiochemical Pharmacology, 1966